F&P Healthcare underperforming, but there's upside to come

F&P Healthcare underperforming, but there's upside to come
Rebecca Howard
Fisher & Paykel Healthcare may be underperforming the S&P NZX50 of late, but there looks to be plenty of upside.  There are two main reasons. First, countries are battling new outbreaks of covid-19. Second, its equipment is now in place to treat a wide variety of respiratory ailments — not just covid. Hospital products make up around 75 percent of its operating revenue. The stock jumped 48 percent in 2020 as it ramped up manufacturing capacity and hired scores of new staff to meet demand for its hospital hardware pr...

More Editor's Picks

Why Savor Group won't sell you lamb cutlets
Markets Small Cap Wrap

Why Savor Group won't sell you lamb cutlets

Plus, its D-day for Tait's Vital takeover, and more.

Expressway bidder faces scrutiny amid Sydney rail allegations
Infrastructure

Expressway bidder faces scrutiny amid Sydney rail allegations

NZTA is monitoring the situation as it assesses a local bid involving Webuild.

Oliver Lewis 11 Sep 2025
ANZ's NZ operation may escape worst of 'Nuno-geddon'
Finance

ANZ's NZ operation may escape worst of 'Nuno-geddon'

ANZ NZ’s performance might be its potential saving grace.

Andy Macdonald 10 Sep 2025
Tariffs tanked markets – NZ Super Fund cashed in
Markets

Tariffs tanked markets – NZ Super Fund cashed in

The Super Fund netted $745 million from active investments. How?